WILMINGTON, Del., April 11, 2016 -- Andrews & Springer LLC, a boutique securities class action law firm focused on representing shareholders nationwide, is investigating potential breach of fiduciary duty claims against Blackrock Capital Investment Corporation (“Blackrock Capital Investment” or the “Company”).
If you currently own units of Blackrock Capital Investment and want to receive additional information and protect your investments free of charge, please visit us at http://www.andrewsspringer.com/cases-investigations/blackrock-capital-investment-class-action-investigation or contact Craig J. Springer, Esq. at [email protected], or call toll free at 1-800-423-6013. You may also follow us on LinkedIn – www.linkedin.com/company/andrews-&-springer-llc, Twitter – www.twitter.com/AndrewsSpringer or Facebook - www.facebook.com/AndrewsSpringer for future updates.
Andrews & Springer is a boutique securities class action law firm representing shareholders nationwide who are victims of securities fraud, breaches of fiduciary duty or corporate misconduct. Having formerly defended some of the largest financial institutions in the world, our founding members use their valuable knowledge, experience, and superior skill for the sole purpose of achieving positive results for investors. These traits are the hallmarks of our innovative approach to each case our Firm decides to prosecute. For more information please visit our website at www.andrewsspringer.com. This notice may constitute Attorney Advertising.
Contact: Craig J. Springer, Esq. [email protected] Toll Free: 1-800-423-6013


Chevron Seeks Expanded U.S. License to Boost Venezuelan Oil Exports Amid Sanctions Talks
Elon Musk Says X Will Open-Source Its Algorithm Amid EU Scrutiny
Trump Pushes $100 Billion U.S. Oil Investment Plan for Venezuela After Maduro Seizure
OpenAI Sets $50 Billion Stock Grant Pool, Boosting Employee Equity and Valuation Outlook
Stellantis to End Plug-In Hybrid Sales in the U.S. as Demand Shifts Toward Traditional Hybrids
Johnson & Johnson Secures Tariff Exemption by Agreeing to Lower Drug Prices in the U.S.
Hanwha Ocean Shares Rise on Plans to Expand U.S. Shipbuilding Capacity
UBS Upgrades L’Oréal to Buy, Sees Strong Sales Momentum and 20% Upside
GM Takes $6 Billion EV Write-Down as Electric Vehicle Demand Slows in the U.S.
AustralianSuper Backs BlueScope Steel’s Rejection of $9 Billion Takeover Bid
Rio Tinto–Glencore Talks Spark Pressure on BHP as Copper Fuels Mining Mega Deals
Aktis Oncology Prices Upsized IPO at $18, Raising $318 Million in Major Biotech Debut
Boeing 737 MAX 10 Advances in FAA Testing as Certification Delays Continue
FCC Approves Expansion of SpaceX Starlink Network With 7,500 New Satellites
xAI Cash Burn Highlights the High Cost of Competing in Generative AI
Allegiant to Acquire Sun Country Airlines in $1.5 Billion Deal to Expand U.S. Leisure Travel Network
Anthropic Launches HIPAA-Compliant Healthcare Tools for Claude AI Amid Growing Competition 



